(-)-epigallocatechin 3-gallate multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATXN2 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATXN2 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression EXP 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ATXN2 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atxn2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATXN2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Atxn2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATXN2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Atxn2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ATXN2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases phosphorylation ISO Atxn2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased phosphorylation of ATXN2 protein CTD PMID:23298284 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ATXN2 mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression ISO Atxn2 (Rattus norvegicus) 6480464 2 and 6-dinitrotoluene affects the expression of ATXN2 mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATXN2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATXN2 mRNA CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of ATXN2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATXN2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bisphenol S affects the methylation of ATXN2 gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of ATXN2 mRNA CTD PMID:28973697 7,9-dihydro-1H-purine-2,6,8(3H)-trione affects abundance ISO ATXN2 (Homo sapiens) 6480464 ATXN2 gene SNP affects the abundance of Uric Acid CTD PMID:23263486 aflatoxin B1 affects methylation ISO ATXN2 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of ATXN2 intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO ATXN2 (Homo sapiens) 6480464 Tretinoin results in decreased expression of ATXN2 mRNA CTD PMID:33167477 arsane affects methylation ISO ATXN2 (Homo sapiens) 6480464 Arsenic affects the methylation of ATXN2 gene CTD PMID:25304211 arsenic atom affects methylation ISO ATXN2 (Homo sapiens) 6480464 Arsenic affects the methylation of ATXN2 gene CTD PMID:25304211 benzo[a]pyrene multiple interactions EXP 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ATXN2 mRNA] CTD PMID:22228805 bisphenol A increases expression ISO Atxn2 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of ATXN2 mRNA CTD PMID:25181051 and PMID:30816183 bisphenol A decreases methylation ISO ATXN2 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of ATXN2 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATXN2 mRNA CTD PMID:33221593 bisphenol A multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATXN2 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO ATXN2 (Homo sapiens) 6480464 bisphenol B results in increased expression of ATXN2 protein CTD PMID:34186270 Brodifacoum decreases expression ISO Atxn2 (Rattus norvegicus) 6480464 bromfenacoum results in decreased expression of ATXN2 protein CTD PMID:28903499 cadmium atom multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATXN2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ATXN2 mRNA CTD PMID:35301059 cadmium sulfate increases expression ISO ATXN2 (Homo sapiens) 6480464 cadmium sulfate results in increased expression of ATXN2 mRNA CTD PMID:14676411 and PMID:21783983 caffeine affects phosphorylation ISO ATXN2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of ATXN2 protein CTD PMID:35688186 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of ATXN2 mRNA CTD PMID:29156651 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of ATXN2 mRNA CTD PMID:37019170 cisplatin decreases expression ISO ATXN2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of ATXN2 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ATXN2 mRNA CTD PMID:27392435 clobetasol decreases expression EXP 6480464 Clobetasol results in decreased expression of ATXN2 mRNA CTD PMID:27462272 coumarin affects phosphorylation ISO ATXN2 (Homo sapiens) 6480464 coumarin affects the phosphorylation of ATXN2 protein CTD PMID:35688186 cyclosporin A increases expression ISO ATXN2 (Homo sapiens) 6480464 Cyclosporine results in increased expression of ATXN2 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATXN2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATXN2 mRNA CTD PMID:28628672 dicrotophos increases expression ISO ATXN2 (Homo sapiens) 6480464 dicrotophos results in increased expression of ATXN2 mRNA CTD PMID:28302478 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of ATXN2 mRNA CTD PMID:24205000 dioxygen affects methylation EXP 6480464 Oxygen deficiency affects the methylation of ATXN2 promoter CTD PMID:24205000 doxorubicin decreases expression ISO ATXN2 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ATXN2 mRNA CTD PMID:29803840 enzyme inhibitor multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATXN2 protein CTD PMID:23301498 epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of ATXN2 mRNA CTD PMID:35436446 FR900359 affects phosphorylation ISO ATXN2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of ATXN2 protein CTD PMID:37730182 fulvestrant increases methylation ISO ATXN2 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of ATXN2 gene CTD PMID:31601247 gallic acid increases expression ISO ATXN2 (Homo sapiens) 6480464 Gallic Acid results in increased expression of ATXN2 mRNA CTD PMID:34408198 gentamycin increases expression ISO Atxn2 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of ATXN2 mRNA CTD PMID:22061828 and PMID:33387578 glafenine decreases expression ISO Atxn2 (Rattus norvegicus) 6480464 Glafenine results in decreased expression of ATXN2 mRNA CTD PMID:24136188 hydralazine multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN2 mRNA CTD PMID:17183730 indometacin multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ATXN2 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ATXN2 mRNA CTD PMID:28628672 inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATXN2 mRNA CTD PMID:36331819 ivermectin decreases expression ISO ATXN2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of ATXN2 protein CTD PMID:32959892 lead(0) affects splicing ISO ATXN2 (Homo sapiens) 6480464 Lead affects the splicing of ATXN2 mRNA CTD PMID:28903495 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of ATXN2 mRNA CTD PMID:36914120 oxidopamine increases expression ISO Atxn2 (Rattus norvegicus) 6480464 Oxidopamine results in increased expression of ATXN2 mRNA CTD PMID:25129099 oxidopamine multiple interactions ISO Atxn2 (Rattus norvegicus) 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA] more ... CTD PMID:25129099 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of ATXN2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO Atxn2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of ATXN2 mRNA CTD PMID:33387578 paraquat affects splicing EXP 6480464 Paraquat affects the splicing of ATXN2 exon CTD PMID:27111068 perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ATXN2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATXN2 mRNA CTD PMID:36331819 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of ATXN2 mRNA CTD PMID:23091169 potassium chromate multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATXN2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO ATXN2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of ATXN2 mRNA CTD PMID:22079256 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of ATXN2 mRNA CTD PMID:21278054 quercetin 3-O-beta-D-glucofuranoside multiple interactions ISO Atxn2 (Rattus norvegicus) 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA] CTD PMID:25129099 quercetin 3-O-beta-D-glucopyranoside multiple interactions ISO Atxn2 (Rattus norvegicus) 6480464 isoquercitrin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA] CTD PMID:25129099 rutin multiple interactions ISO Atxn2 (Rattus norvegicus) 6480464 Rutin inhibits the reaction [Oxidopamine results in increased expression of ATXN2 mRNA] CTD PMID:25129099 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of ATXN2 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO Atxn2 (Rattus norvegicus) 6480464 sodium arsenite results in increased expression of ATXN2 mRNA CTD PMID:19072884 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ATXN2 mRNA CTD PMID:31919559 thioacetamide decreases expression ISO Atxn2 (Rattus norvegicus) 6480464 Thioacetamide results in decreased expression of ATXN2 mRNA CTD PMID:34492290 triptonide affects expression EXP 6480464 triptonide affects the expression of ATXN2 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ATXN2 mRNA CTD PMID:28973697 urethane increases expression ISO ATXN2 (Homo sapiens) 6480464 Urethane results in increased expression of ATXN2 mRNA CTD PMID:28818685 valproic acid increases methylation ISO ATXN2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ATXN2 gene CTD PMID:29154799 valproic acid multiple interactions ISO ATXN2 (Homo sapiens) 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of ATXN2 mRNA CTD PMID:17183730 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of ATXN2 mRNA CTD PMID:17292431 valproic acid affects expression ISO ATXN2 (Homo sapiens) 6480464 Valproic Acid affects the expression of ATXN2 mRNA CTD PMID:25979313